Hypertension Diagnostics PulseWave 510(k) Submission Anticipated This Year
This article was originally published in The Gray Sheet
Hypertension Diagnostics plans to submit a 510(k) by the end of 1998 for its HDI/PulseWave DO-2020 cardiovascular profiling instrument, the company states in a May 19 filing with the Securities and Exchange Commission for an initial public offering.
You may also be interested in...
Hypertension Diagnostics, Inc. is conducting additional prospective clinical trials of its CVProfilor DO-2020 cardiovascular profiling instrument to support a second 510(k) submission after an initial submission was deemed inadequate by FDA, the firm says. The filing is expected in the first half of this year.
China's centralized procurement scheme, if further expanded after causing the prices of 32 drugs to be cut by more than half in the latest round, will leave companies no room to breathe easy amid the already devastating coronavirus outbreak, analysts say.